Pharmacotherapeutic treatment of germ cell tumors: standard of care and recent developments.

about

Pharmacotherapeutic treatment of germ cell tumors: standard of care and recent developments.

Item

http://www.wikidata.org/entity/Q38656908

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Pharmacotherapeutic treatment ...... care and recent developments.

@en

type

Item

label

Pharmacotherapeutic treatment ...... care and recent developments.

@en

prefLabel

Pharmacotherapeutic treatment ...... care and recent developments.

@en

P1476

Pharmacotherapeutic treatment ...... f care and recent developments

@en

P2093

Carsten Bokemeyer

http://www.w3.org/2001/XMLSchema#string

Christoph Seidel

http://www.w3.org/2001/XMLSchema#string

Gunhild von Amsberg

http://www.w3.org/2001/XMLSchema#string

Karin Oechsle

http://www.w3.org/2001/XMLSchema#string

P2860

Personalizing, not patronizing: the case for patient autonomy by unbiased presentation of management options in stage I testicular cancer

Contralateral biopsies in patients with testicular germ cell tumours: patterns of care in Germany and recent data regarding prevalence and treatment of testicular intra-epithelial neoplasia.

A phase 2 multicenter study of tivantinib (ARQ 197) monotherapy in patients with relapsed or refractory germ cell tumors.

Long-term experience with carboplatin monotherapy for clinical stage I seminoma: a retrospective single-center study.

Gemcitabine and oxaliplatin (GEMOX) in patients with cisplatin-refractory germ cell tumors: a phase II study.

Oxaliplatin and irinotecan plus granulocyte-colony stimulating factor as third-line treatment in relapsed or cisplatin-refractory germ-cell tumor patients: a phase II study.

Combination chemotherapy with gemcitabine, oxaliplatin, and paclitaxel in patients with cisplatin-refractory or multiply relapsed germ-cell tumors: a study of the German Testicular Cancer Study Group.

Retrospective multicentre study of carboplatin monotherapy for clinical stage I seminoma.

A risk-adapted study of cisplatin and etoposide, with or without ifosfamide, in patients with metastatic seminoma: results of the GETUG S99 multicenter prospective study.

Randomized phase III study comparing paclitaxel-bleomycin, etoposide, and cisplatin (BEP) to standard BEP in intermediate-prognosis germ-cell cancer: intergroup study EORTC 30983.

P304

545-560

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14656566.2016.1127357

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Christoph Oing

P577

2015-12-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26630452

http://www.w3.org/2001/XMLSchema#string